Artificial heart newer versions, such as the Heartmate II, developed by The Texas Heart Institute of Houston, provide continuous flow. These pumps (which may be centrifugal or axial flow) are smaller and potentially more durable and last longer than the current generation of total heart replacement pumps. Another major advantage of a VAD is that the patient keeps the natural heart, which may still function for temporary back-up support if the mechanical pump were to stop. This may provide enough support to keep the patient alive until a solution to the problem is implemented. In August 2006, an artificial heart was implanted
Rayner (company) London, Ridley performed the first IOL operation on the eye of a 45-year-old female patient. The operation was conducted in secret, done in two stages with the artificial lens permanently implanted three months later. In 1952 the first IOL implant was performed in the United States: a Ridley-Rayner lens was implanted at the Wills Eye Hospital in Philadelphia. Surgeons Turgut Hamdi MD and Warren Reese MD implanted a series of these lenses – some with good visual function results (reported in a review by Dr Charles Letocha in the "Journal of Cataract and Refractive Surgery" in 1999). A lens designed